# FDA Inspection 1165379 - Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb - March 18, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/juno-therapeutics-inc-a-subsidiary-of-bristol-myers-squibb/1cb15bd3-1666-4ed4-9c26-58a4519a63c5/
Source feed: FDA_Inspections

> FDA Inspection 1165379 for Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb on March 18, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165379
- Company Name: Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb
- Inspection Date: 2022-03-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1165379 - 2022-03-18](https://www.globalkeysolutions.net/api/records/fda_inspections/juno-therapeutics-inc-a-subsidiary-of-bristol-myers-squibb/9423620c-59dd-4b52-bd8b-f35b1a3df777/)
- [FDA Inspection 1091219 - 2019-05-15](https://www.globalkeysolutions.net/api/records/fda_inspections/juno-therapeutics-inc-a-subsidiary-of-bristol-myers-squibb/89b25f8e-a86e-4e63-b5fe-8315960c6869/)

Company: https://www.globalkeysolutions.net/companies/juno-therapeutics-inc-a-subsidiary-of-bristol-myers-squibb/fff03cc2-ba14-4ac1-b81c-88b6bebad784

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d